School nurses as anxiety coaches? a new program aims to help kids cope
NCT ID NCT04693858
First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time
Summary
This trial tests whether a brief program called CALM, delivered by school nurses, can reduce excessive anxiety in children aged 5 to 12. The program teaches relaxation, facing fears, and changing anxious thoughts over eight weeks. It is compared to a relaxation-only approach and a waitlist. The study also looks at whether CALM improves school outcomes and is cost-effective.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Child Anxiety Learning Modules (CALM), a cognitive-behavioral intervention delivered by school nurses over 8 weeks
- What this could lead to
- If effective, this could provide a practical, school-based way to help children with anxiety, potentially improving their academic and social functioning without needing specialized mental health care.
- What could go wrong
- The trial is relatively small and early-stage, and the benefits may not last beyond the follow-up period. As with any behavioral intervention, results may vary widely among children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 218 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Dec 2020
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 12 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Student Inclusion Criteria: * Be between the ages of 5-12 * Have elevated anxiety symptoms as indicated by a) a total SCARED score of 15 or higher based on parent and/or child report using the full SCARED from the baseline evaluation, and/or b) a Clinician Severity Rating of 3 or higher on any anxiety diagnosis from the Anxiety Disorders Interview Schedule for Children DSM-V (ADIS) * Be fluent in English in order to provide informed consent and assent for their participation and to complete the study measures. * Children on a stable dose of pharmacological/psychotherapeutic treatment will be eligible as long as the dose has been stable for at least 4 weeks and no changes are considered for the duration of the intervention phase of the study (8 weeks) Student Exclusion Criteria: * Children who do not meet the inclusion criteria Nurse Inclusion Criteria: * Nurses must be a Registered Nurse (RN) or another similar medical professional * Nurses must be work in the role of a school nurse * Nurses must be fluent in English
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety disorder of childhood are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anxiety Treatment Center of Maryland
Columbia, Maryland, 21045, United States
-
University of Connecticut School of Medicine
West Hartford, Connecticut, 06119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.